VGXI, Inc.

11 articles about VGXI, Inc.

• Stephanie Burke Named as VGXI's New Chief Accounting Officer

  3/27/2024

  VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, is pleased to announce the appointment of Stephanie Burke as the Chief Accounting Officer for VGXI.

• VGXI Welcomes Michael Stewart as New Chief Operating Officer

  3/4/2024

  VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, proudly announces the appointment of Michael Stewart as its new Chief Operating Officer.

• VGXI Announces Strategic Multi-Year Partnership with Resilience to Accelerate Biomanufacturing of Advanced Medicines

  1/24/2024

  VGXI, Inc. have entered a strategic multi-year partnership.

• 

  Biopharma Update on the Novel Coronavirus: June 5

  6/5/2020

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.

• VGXI, Inc. Establishes Pilot mRNA Manufacturing Capabilities

  12/6/2019

  Under a Technology License Agreement with the Houston Methodist Research Institute, Contract Developer and Manufacturer VGXI Achieves Key Milestones with Establishment of Pilot Production Capabilities for RNA-Based Medicines.

• VGXI Selects BE&K as Design-Build Partner for New Manufacturing Facility

  12/3/2019

  Plasmid DNA Manufacturer VGXI, Inc. Selects BE&K Building Group as its Design-Build Partner for the Initial Phase of its New and Expanded Manufacturing Facility

• VGXI, Inc. Celebrates Facility Expansion Grand Opening

  6/3/2016

• Positive Data Announced In Phase IIb Clinical Trial Of Cystic Fibrosis Gene Therapy Manufactured By VGXI, Inc.

  7/9/2015

• VGXI, Inc. Announces Expansion Of Its Manufacturing Facility

  12/16/2014

• OncoSec Medical Inc. Signs cGMP Manufacturing Agreement With VGXI, Inc.

  6/5/2012

• VGXI, Inc. Expands Manufacturing Facility, Adds Key Personnel

  3/5/2010